Source: Lab Bulletin

Scipio Bioscience: Scipio bioscience Announces a Single-Cell Grant Program for Four Researchers to Receive a Complete 3 scRNA-seq Solution Valued up to US$30,000

With the debut of its novel single-cell solution and its first Grant Program, Scipio bioscience is creating an era where scRNA-seq is versatile, flexible, and accessible for every lab. Introduced just six months ago, the Scipio bioscience single-cell RNA-seq solution includes the Asteria Benchtop Kit and the Cytonaut Cloud Analysis Software. This powerful kit and software combination is delivering on the promise of a much-simplified workflow, never-experienced-before flexibility, and greater ease and confidence in data analysis...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Pierre Walrafen's photo - Co-Founder & CEO of Scipio Bioscience

Co-Founder & CEO

Pierre Walrafen

CEO Approval Rating

74/100

Read more